ESC 2025: the focused update of the ESC/EAS dyslipidaemia guidelines, discussed (Roeters van Lennep, Van Spall)

Late-breaker host Harriette Van Spall (McMaster) with Jeanine Roeters van Lennep (Erasmus MC, Rotterdam), a task-force member, on the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: what changed for LDL-C targets and combination therapy, and where lipoprotein(a) now sits in risk assessment (measure at least once, use it as a risk modifier, treat the surrounding risk aggressively while the outcomes trials read out). Recorded at ESC Congress 2025.